Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Chinese Patent Office
Cerilliant
QuintilesIMS
Accenture
Argus Health
Healthtrust
US Department of Justice
Covington

Generated: November 18, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Vadimezan

« Back to Dashboard

US Patents for Vadimezan

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Vadimezan ➤ Sign Up Compounds having antitumor and antibacterial properties Cancer Research Campaign Technology Limited (London, GB2) ➤ Sign Up
Vadimezan ➤ Sign Up Corticosteroid 17-alkyl carbonate 21-[0]-carboxylic and carbonic esters, and pharmaceuticals containing these compounds Hoechst Aktiengesellschaft (Frankfurt am Main, DE) ➤ Sign Up
Vadimezan ➤ Sign Up 17-deoxycorticosteroid-21-[O]carboxylic esters, processes for their preparation and pharmaceuticals containing these compounds Hoechst Aktiengesellschaft (Frankfurt am Main, DE) ➤ Sign Up
Vadimezan ➤ Sign Up Method for treating hyperproliferative tissue in a mammal Health Research, Inc. (Buffalo, NY) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Vadimezan

Drugname Country Document Number Estimated Expiration Related US Patent
Vadimezan Austria 102616 2006-12-23 ➤ Sign Up
Vadimezan Germany 3789299 2006-12-23 ➤ Sign Up
Vadimezan European Patent Office 0278176 2006-12-23 ➤ Sign Up
Vadimezan Spain 2061518 2006-12-23 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Express Scripts
Baxter
Covington
Medtronic
Boehringer Ingelheim
Cipla
UBS
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.